CASE DISCUSSION
Treatment of Renal Disease in ANCA Vasculitis
Presented from India by Dr. Amitabh Kulkarni0
Likes
2696
Views
108
Shares
135
Bookmarks
0
Credit Points
0
Learning Hours
0
CPD/CME Points
0
Courses Completed
Case Description
The treatment of renal disease in ANCA-associated vasculitis (AAV) typically involves a combination of immunosuppressive therapies to control inflammation and prevent further kidney damage. First-line treatment often includes high-dose corticosteroids and cyclophosphamide or rituximab, both of...
Case Summary
- The speaker discusses Anca-associated vasculitis, a clinical topic frequently encountered. The presentation covers a case study, definition of Anca (anti-neutrophil cytoplasmic antibody) and vasculitis, classification of vasculitis, diagnosis and identification of Anca-associated vasculitis.
Speaker Profile
Dr. Amitabh Kulkarni
Head of Department, Nephrology, NMC Speciality Hospital, DubaiDisclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.